Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter E Penson

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Age and Ageing|February 24, 2024
Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003-18Leona A Ritchie, Stephanie L Harrison, Peter E Penson, et al.
Age and Ageing|December 5, 2022
Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018Leona A Ritchie, Stephanie L Harrison, Peter E Penson, et al.
Journal of Personalized Medicine|April 23, 2022
Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study ProtocolIan D Jones, Deirdre A Lane, Robyn R Lotto, et al.
Pharmacological Research|February 10, 2023
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)Manfredi Rizzo, Alessandro Colletti, Peter E Penson, et al.
Journal of Hypertension|August 12, 2016
Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trialsDaniel Brie, Amirhossein Sahebkar, Peter E Penson, et al.
Archives of Medical Science : AMS|December 9, 2024
Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS): study design and methodologyMaciej Banach, Martyna Fronczek, Tadeusz Osadnik, et al.
Pharmacological Research|July 28, 2022
Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert PanelMaciej Banach, Alberico L Catapano, Arrigo F G Cicero, et al.
The Lancet Regional Health. Europe|March 6, 2025
Correction to "Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)" [The Lancet Regional Health - Europe 49 (2025) 101182]Yang Chen, Ziyi Zhong, Ying Gue, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)Yang Chen, Ziyi Zhong, Ying Gue, et al.
Kardiologia Polska|January 26, 2026
The prevalence of obesity and its relationship to cardiometabolic risk factors in the LIPIDOGRAM studiesDariusz Nowak, Martyna Fronczek, Tomasz Czapor, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Age and Ageing|February 24, 2024
Adherence to the Atrial fibrillation Better Care pathway and the risk of adverse health outcomes in older care home residents with atrial fibrillation: a retrospective data linkage study 2003-18Leona A Ritchie, Stephanie L Harrison, Peter E Penson, et al.
Age and Ageing|December 5, 2022
Prevalence and outcomes of atrial fibrillation in older people living in care homes in Wales: a routine data linkage study 2003-2018Leona A Ritchie, Stephanie L Harrison, Peter E Penson, et al.
Journal of Personalized Medicine|April 23, 2022
Supermarket/Hypermarket Opportunistic Screening for Atrial Fibrillation (SHOPS-AF): A Mixed Methods Feasibility Study ProtocolIan D Jones, Deirdre A Lane, Robyn R Lotto, et al.
Pharmacological Research|February 10, 2023
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)Manfredi Rizzo, Alessandro Colletti, Peter E Penson, et al.
Journal of Hypertension|August 12, 2016
Effects of pentoxifylline on inflammatory markers and blood pressure: a systematic review and meta-analysis of randomized controlled trialsDaniel Brie, Amirhossein Sahebkar, Peter E Penson, et al.
Archives of Medical Science : AMS|December 9, 2024
Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS): study design and methodologyMaciej Banach, Martyna Fronczek, Tadeusz Osadnik, et al.
Pharmacological Research|July 28, 2022
Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert PanelMaciej Banach, Alberico L Catapano, Arrigo F G Cicero, et al.
The Lancet Regional Health. Europe|March 6, 2025
Correction to "Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)" [The Lancet Regional Health - Europe 49 (2025) 101182]Yang Chen, Ziyi Zhong, Ying Gue, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact of surrogates for insulin resistance on mortality and life expectancy in primary care: a nationwide cross-sectional study with registry linkage (LIPIDOGRAM2015)Yang Chen, Ziyi Zhong, Ying Gue, et al.
Kardiologia Polska|January 26, 2026
The prevalence of obesity and its relationship to cardiometabolic risk factors in the LIPIDOGRAM studiesDariusz Nowak, Martyna Fronczek, Tomasz Czapor, et al.
Pageof 10